Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 6
2009 1
2010 2
2011 1
2012 1
2013 1
2014 2
2020 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.
DeMaria PJ, Lee-Wisdom K, Donahue RN, Madan RA, Karzai F, Schwab A, Palena C, Jochems C, Floudas C, Strauss J, Marté JL, Redman JM, Dombi E, Widemann B, Korchin B, Adams T, Pico-Navarro C, Heery C, Schlom J, Gulley JL, Bilusic M. DeMaria PJ, et al. Among authors: korchin b. J Immunother Cancer. 2021 Sep;9(9):e003238. doi: 10.1136/jitc-2021-003238. J Immunother Cancer. 2021. PMID: 34479925 Free PMC article. Clinical Trial.
Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ, Das P, Tuvin D, Korchin B, Zhu Q, Jin Z, Warneke CL, Zhang PS, Hernandez V, Lopez-Terrada D, Pisters PW, Pollock RE, Lev D. Lazar AJ, et al. Among authors: korchin b. Clin Cancer Res. 2007 Dec 15;13(24):7314-21. doi: 10.1158/1078-0432.CCR-07-0174. Clin Cancer Res. 2007. PMID: 18094412
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
Hajitou A, Lev DC, Hannay JA, Korchin B, Staquicini FI, Soghomonyan S, Alauddin MM, Benjamin RS, Pollock RE, Gelovani JG, Pasqualini R, Arap W. Hajitou A, et al. Among authors: korchin b. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4471-6. doi: 10.1073/pnas.0712184105. Epub 2008 Mar 12. Proc Natl Acad Sci U S A. 2008. PMID: 18337507 Free PMC article.
Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex.
Konopleva M, Milella M, Ruvolo P, Watts JC, Ricciardi MR, Korchin B, Teresa M, Bornmann W, Tsao T, Bergamo P, Mak DH, Chen W, McCubrey J, Tafuri A, Andreeff M. Konopleva M, et al. Among authors: korchin b. Leukemia. 2024 Sep;38(9):2072. doi: 10.1038/s41375-024-02339-y. Leukemia. 2024. PMID: 39025987 No abstract available.
Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth.
Lu H, Kojima K, Battula VL, Korchin B, Shi Y, Chen Y, Spong S, Thomas DA, Kantarjian H, Lock RB, Andreeff M, Konopleva M. Lu H, et al. Among authors: korchin b. Ann Hematol. 2014 Mar;93(3):485-492. doi: 10.1007/s00277-013-1939-2. Epub 2013 Oct 24. Ann Hematol. 2014. PMID: 24154679 Free PMC article.
High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
Das P, Kotilingam D, Korchin B, Liu J, Yu D, Lazar AJ, Pollock RE, Lev D. Das P, et al. Among authors: korchin b. Cancer. 2007 Jun 1;109(11):2323-33. doi: 10.1002/cncr.22680. Cancer. 2007. PMID: 17429838 Free article.
19 results